nitazoxanide has been researched along with dextrothyroxine in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (6.67) | 18.2507 |
| 2000's | 1 (6.67) | 29.6817 |
| 2010's | 2 (13.33) | 24.3611 |
| 2020's | 11 (73.33) | 2.80 |
| Authors | Studies |
|---|---|
| Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
| Geary, TG; Sangster, NC; Thompson, DP | 1 |
| Bouchaud, O; Izri, A | 1 |
| Aroian, RV; Ellis, BL; Hu, Y; Miller, MM; Shi, LZ; Urban, JF; Yiu, YY | 1 |
| Ellis, BL; May, CJ; Weaver, KJ | 1 |
| Şimşek Yavuz, S; Ünal, S | 1 |
| Anastasiou, IA; Eleftheriadou, I; Tentolouris, A; Tentolouris, N; Tsilingiris, D | 1 |
| Alonso, DF; Farina, HG | 1 |
| Kumar, D; Trivedi, N; Verma, A | 1 |
| Wen, S; Xu, X; Yadav, AK; Yu, L | 1 |
| Abo El Kheir, NY; Alegezy, M; Alhawarey, A; Besheer, T; El-Bendary, M; El-Emshaty, WM; El-Gilany, AH; El-Mesery, A; Elalfy, H; Elhadidy, T; Hewidy, AA; Neamatallah, MAM; Raafat, D; Soliman, MA; Zaghloul, H | 1 |
| Byrne, P; Harrington, P; O Murchu, E; O'Neill, M; Ryan, M; Spillane, S | 1 |
| Tsanni, A | 1 |
| Abdelaal, AA; Afife, AA; Badawi, MA; Fadl, HO; Fahmy, MA; Hassan, SI; Ismail, MAM; Khairy, RA; Shalaby, MA | 1 |
| Al-Obaidi, I; Batchelor, H; Hoerauf, A; Krome, AK; Kuesel, AC; Opoku, NO; Pfarr, KM; Vaillant, M | 1 |
6 review(s) available for nitazoxanide and dextrothyroxine
| Article | Year |
|---|---|
Frontiers in anthelmintic pharmacology.
Topics: Animals; Anthelmintics; Anti-Bacterial Agents; Anti-Infective Agents; ATP Binding Cassette Transporter, Subfamily B; Biological Availability; Caenorhabditis elegans; Cattle; Cattle Diseases; Depsipeptides; Diketopiperazines; Drug Resistance; Helminthiasis, Animal; Helminths; Ivermectin; Macrolides; Nitro Compounds; Peptides, Cyclic; Piperazines; Sheep; Sheep Diseases; Thiazoles | 1999 |
Antiviral treatment of COVID-19
Topics: Adenosine Monophosphate; Alanine; Amides; Antiviral Agents; Betacoronavirus; Chloroquine; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Drug Combinations; Humans; Hydroxychloroquine; Ivermectin; Lopinavir; Nitro Compounds; Pandemics; Pneumonia, Viral; Pyrazines; Ritonavir; SARS-CoV-2; Thiazoles | 2020 |
Possible treatment and strategies for COVID-19: review and assessment.
Topics: Adenosine Monophosphate; Alanine; Amides; Anti-Bacterial Agents; Anti-Inflammatory Agents; Antibodies, Monoclonal, Humanized; Antibodies, Neutralizing; Antiparasitic Agents; Antiviral Agents; Cannabinoids; Chloroquine; Complement Inactivating Agents; COVID-19; COVID-19 Drug Treatment; COVID-19 Serotherapy; COVID-19 Vaccines; Dexamethasone; Drug Combinations; Enzyme Inhibitors; Humans; Hydroxychloroquine; Immunization, Passive; Indoles; Interferons; Ivermectin; Lopinavir; Nitro Compounds; Pyrazines; Ritonavir; SARS-CoV-2; Teicoplanin; Tetracyclines; Thiazoles | 2020 |
Antiviral treatment in COVID-19: which is the most promising?-a narrative review.
Topics: Adenosine Monophosphate; Alanine; Amides; Antibodies, Monoclonal, Humanized; Antiviral Agents; Azetidines; Chloroquine; COVID-19; COVID-19 Serotherapy; Drug Combinations; Humans; Hydroxychloroquine; Immunization, Passive; Indoles; Interferons; Ivermectin; Lopinavir; Nitro Compounds; Oseltamivir; Purines; Pyrazines; Pyrazoles; Ribavirin; Ritonavir; Sulfonamides; Thiazoles | 2021 |
Interventions in an Ambulatory Setting to Prevent Progression to Severe Disease in Patients With COVID-19: A Systematic Review.
Topics: Ambulatory Care; Antibodies, Monoclonal, Humanized; Antibodies, Neutralizing; Antiviral Agents; COVID-19; Disease Progression; Humans; Interferons; Ivermectin; Nitro Compounds; Polyethylene Glycols; Thiazoles | 2022 |
The pipeline for drugs for control and elimination of neglected tropical diseases: 2. Oral anti-infective drugs and drug combinations for off-label use.
Topics: Anti-Infective Agents; Doxycycline; Drug Combinations; Fluconazole; Humans; Ivermectin; Neglected Diseases; Off-Label Use; Rifampin | 2023 |
1 trial(s) available for nitazoxanide and dextrothyroxine
| Article | Year |
|---|---|
Effect of a combination of nitazoxanide, ribavirin, and ivermectin plus zinc supplement (MANS.NRIZ study) on the clearance of mild COVID-19.
Topics: Adult; Antimetabolites; Antiparasitic Agents; COVID-19 Drug Treatment; Female; Humans; Ivermectin; Male; Nitro Compounds; Ribavirin; SARS-CoV-2; Thiazoles; Trace Elements; Zinc | 2021 |
8 other study(ies) available for nitazoxanide and dextrothyroxine
| Article | Year |
|---|---|
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |
[New antiparasitic drugs].
Topics: Albendazole; Antimalarials; Antiparasitic Agents; Benzimidazoles; Cyclohexanes; Fatty Acids, Unsaturated; Humans; Ivermectin; Nitro Compounds; Phosphorylcholine; Praziquantel; Sesquiterpenes; Thiazoles; Triclabendazole | 2008 |
An extensive comparison of the effect of anthelmintic classes on diverse nematodes.
Topics: Albendazole; Animals; Anthelmintics; Cricetinae; Drug Resistance; Female; Ivermectin; Male; Mice; Nematoda; Nematode Infections; Nitro Compounds; Parasitic Sensitivity Tests; Pyrantel; Species Specificity; Thiazoles | 2013 |
Using a health-rating system to evaluate the usefulness of Caenorhabditis elegans as a model for anthelmintic study.
Topics: Albendazole; Animals; Anthelmintics; Caenorhabditis elegans; Helminthiasis; Humans; Inhibitory Concentration 50; Ivermectin; Lethal Dose 50; Nitro Compounds; Parasitic Sensitivity Tests; Pyrantel; Thiazoles | 2017 |
In Vitro Data of Current Therapies for SARS-CoV-2.
Topics: Adenosine Monophosphate; Alanine; Betacoronavirus; China; Chloroquine; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Drug Repositioning; Emetine; Homoharringtonine; Humans; Hydroxychloroquine; Ivermectin; Lopinavir; Nitro Compounds; Pandemics; Pneumonia, Viral; SARS-CoV-2; Teicoplanin; Thiazoles | 2020 |
Repurposing of host-based therapeutic agents for the treatment of coronavirus disease 2019 (COVID-19): a link between antiviral and anticancer mechanisms?
Topics: Anticholesteremic Agents; Antineoplastic Agents; Antiparasitic Agents; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; Drug Administration Schedule; Drug Repositioning; Host-Pathogen Interactions; Humans; Hypoglycemic Agents; Ivermectin; Lovastatin; Metformin; Nitro Compounds; Pandemics; Pneumonia, Viral; SARS-CoV-2; Severity of Illness Index; Thiazoles | 2020 |
African scientists race to test COVID drugs - but face major hurdles.
Topics: Africa; Amides; Amodiaquine; Artesunate; Atazanavir Sulfate; Carbamates; Clinical Trials as Topic; COVID-19; COVID-19 Drug Treatment; COVID-19 Vaccines; Cytidine; Drug Approval; Drug Evaluation, Preclinical; Drug Repositioning; Drug Therapy, Combination; Humans; Hydroxylamines; Imidazoles; Ivermectin; Naphthyridines; Nitro Compounds; Pregnenediones; Pyrazines; Pyrrolidines; Ritonavir; Sample Size; Thiazoles; Valine; World Health Organization | 2021 |
Antiparasitic and immunomodulating effects of nitazoxanide, ivermectin and selenium on Cryptosporidium infection in diabetic mice.
Topics: Animals; Antiparasitic Agents; Cryptosporidiosis; Cryptosporidium; Diabetes Mellitus, Experimental; Ivermectin; Mice; Nitro Compounds; Rodent Diseases; Selenium; Thiazoles | 2021 |